{
  "id": 8435,
  "date": "2019-05-28T15:42:19",
  "date_gmt": "2019-05-28T15:42:19",
  "guid": { "rendered": "./?p=8435" },
  "modified": "2019-05-28T16:21:43",
  "modified_gmt": "2019-05-28T16:21:43",
  "slug": "regulatory-times-april-2019",
  "status": "publish",
  "type": "post",
  "link": "./blog/regulatory-times-april-2019/",
  "title": { "rendered": "The Regulatory Times &#8211; April 2019" },
  "content": {
    "rendered": "<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><ul class=\"fusion-checklist fusion-checklist-1\" style=\"font-size:13px;line-height:22.1px;\"><li class=\"fusion-li-item\"><span style=\"height:22.1px;width:22.1px;margin-right:9.1px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa fa-arrow-left\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:31.2px;\">\n<p><a href=\"./blog/\">Back to Kinapse blog</a></p>\n</div></li></ul><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#253745;padding: 3% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\">The Regulatory Times</span></h1></h2></div><div class=\"fusion-text fusion-text-1\"><h6 style=\"text-align: center;\"><span style=\"color: #ffffff;\">April 2019</span></h6>\n</div><div class=\"fusion-text fusion-text-2\"><p style=\"text-align: center;\"><span style=\"color: #f2f2f2;\">Your monthly round-up of international Life Sciences regulatory news from the past month</span></p>\n</div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:teal;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: #ffffff;\">US</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-3\"><p><span style=\"color: #1d866c;\"><strong>Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act</strong></span></p>\n<p>This guidance explains the FDA\u2019s policy for evaluating bulk drug substances nominated for use in compounding by outsourcing facilities registered under section 503B of the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act). Section 503B of the FD&amp;C Act directs the FDA to develop a list of bulk drug substances for which there is a clinical need (the 503B Bulks List). Drug products compounded using bulk drug substances on the 503B Bulks list qualify for certain exemptions from the FD&amp;C Act, provided the other conditions in section 503B are met. This guidance addresses FDA policies for developing the 503B Bulks List, including the Agency\u2019s interpretation of the phrase \u2018bulk drug substances for which there is a clinical need\u2019, as it is used in section 503B. This guidance also addresses the factors and processes by which the Agency intends to evaluate and list bulk drug substances.</p>\n<p>Drug products compounded under the conditions in section 503B are not exempt from current good manufacturing practice (CGMP) requirements in section 501(a)(2)(B) of the FD&amp;C Act.</p>\n<p>Bulk drug substances used in compounding under section 503B must also meet certain other statutory requirements, including the following:</p>\n<ol>\n<li>If an applicable monograph exists under the United States Pharmacopeia (USP), National Formulary (NF), or another compendium or pharmacopeia recognized by the Secretary under section 503B, the bulk drug substance must comply with the monograph;</li>\n<li>The bulk drug substance must be manufactured by an analysis.</li>\n</ol>\n<p>A more detailed discussion of the analysis is included in this guidance to evaluate bulk drug substances that have been nominated for inclusion on the 503B Bulks list.</p>\n<p><em>For details please refer to the link provided below:</em></p>\n<p><a href=\"https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM602276.pdf\"><span style=\"color: teal;\"><strong>FDA Website</strong></span></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;max-width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#ffffff;border-top-width:30px;\"></div></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:teal;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: #ffffff;\">EU</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_2 1_2 fusion-one-half fusion-column-first\" style=\"width:50%;width:calc(50% - ( ( 4% ) * 0.5 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-4\"><p><span style=\"color: #1d866c;\"><strong>The MHRA Offers No-Deal Guidance on Pharmaceutical Product Certificates</strong></span></p>\n<p>The MHRA has published additional guidance covering the process for applying for a Certificate of Pharmaceutical Product (CPP) in case the UK leaves the EU without a deal.</p>\n<p>If this happens, the MHRA will become the UK\u2019s stand-alone medicines and medical devices regulator, taking any decisions and carrying out any functions which are currently taken or carried out at EU-level.</p>\n<p>The MHRA will continue to offer existing services for issuing a Certificate of Pharmaceutical Product (CPP). The normal service takes 10 days and a 2-day service is available for urgent requests.</p>\n<p>If the UK leaves the EU without a deal, the MHRA will be able to issue a CPP for a grandfathered centrally authorised product (CAP). A grandfathered CAP is a CAP marketing authorization automatically converted to a UK marketing authorization.</p>\n<p><em>Follow the Gov.UK </em><em>links below\u00a0for full details:</em></p>\n<p><a href=\"https://www.gov.uk/government/collections/mhra-guidance-and-publications-on-a-possible-no-deal-scenario\"><strong>MHRA Guidance\u00a0and\u00a0Publications\u00a0on\u00a0a\u00a0Possible\u00a0No-Deal\u00a0Scenario</strong></a></p>\n<p><a href=\"https://www.gov.uk/guidance/applying-for-a-certificate-of-pharmaceutical-product-in-a-no-deal-scenario\"><strong>Applying\u00a0for\u00a0a\u00a0Certificate\u00a0of\u00a0Pharmaceutical\u00a0Product\u00a0in\u00a0a\u00a0No-Deal\u00a0Scenario</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_2 1_2 fusion-one-half fusion-column-last\" style=\"width:50%;width:calc(50% - ( ( 4% ) * 0.5 ) );margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-2 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-5\"><p><span style=\"color: #1d866c;\"><strong>Mandate of the Joint CMDh/CMDv Working Party on Variation Regulation</strong></span></p>\n<p>The mandate of the Working Party on Variation Regulation was established to provide recommendations to the CMDh and CMDv on below matters:</p>\n<ul>\n<li>To prepare proposals for updated CMD guidance and documents to the revised Variation Regulation</li>\n<li>To give inputs to EC proposals, e.g. for future update of guidelines and application forms</li>\n<li>To reach a common interpretation of the revised Variation Regulation in order to ensure a consistent approach with regards to variation procedures</li>\n<li>To discuss common topics with the EMA such as recommendations on the classification of unforeseen variations and work sharing.</li>\n<li>To promote the use of the work-sharing procedure.</li>\n</ul>\n<p><em>Follow the link for full details:</em></p>\n<p><a href=\"http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/CMD_subgroups_working_groups/Variations/CMDh_CMDv_059_2008_Rev.3_2019_03_clean_VRWP_Mandate.pdf\"><strong>HMA Website</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:teal;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: #ffffff;\">Emerging Markets</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: teal;\">India</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-9 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-3 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-6\"><p><span style=\"color: #1d866c;\"><strong>New Drugs and Clinical Trials Rules 2019</strong></span></p>\n<p>These rules lay out regulations for new drugs as well as the approval and conduct of clinical trials in India. Relevant forms are annexed for submissions made under these rules.</p>\n<p><em>Follow the link below for full details:</em></p>\n<p><a href=\"https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDrugs_CTRules_2019.pdf\"><strong>CDSCO\u00a0Website</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-10 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: teal;\">Australia</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-11 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-4 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-7\"><p><span style=\"color: #1d866c;\"><strong>Guidance for TGO 101: Standard for Tablets, Capsules and Pills v1.0, April 2019</strong></span></p>\n<p>This guidance is to help sponsors and manufacturers of medicines understand the role of the Therapeutic Goods Order No. 101 &#8211; Standard for tablets, capsules and pills (TGO 101, the Order) in ensuring that these types of therapeutic goods are of appropriate quality.</p>\n<p>The information in this guidance may also assist other stakeholders to understand how sponsors and manufacturers assure that medicines that are tablets, capsules or pills are of good quality.</p>\n<p>Compliance with TGO 101 is not necessarily sufficient to demonstrate quality, safety or efficacy for the purposes of registering or listing a medicine. Additional requirements may be applied, for example, as conditions of listing or conditions of registration.</p>\n<p>In some instances, compliance with TGO 101 may not be sufficient to establish the safe use of medicines. Sponsors will need to further consider the intended patient population, size of the recommended daily dose, etc. to ensure that their medicines are safe for the purpose for which they are to be used.</p>\n<p>Consideration must also be given to any other relevant standards.</p>\n<p><em>Follow the link below for full details:</em></p>\n<p><a href=\"https://www.tga.gov.au/publication/guidance-tgo-101\"><strong>TGA\u00a0Website</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:3%;padding-right:0px;padding-bottom:3%;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-12 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-13 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-7 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:10px;margin-left:0px;\"><h1 class=\"title-heading-left\" style=\"margin:0;\"><h5><span style=\"color: #000000;\">Share this page:</span></h5></h1></div><div class=\"fusion-widget-area fusion-widget-area-1 fusion-content-widget-area\"><style type=\"text/css\">.fusion-widget-area-1 {padding:0px 0px 0px 0px;}.fusion-widget-area-1 .widget h4 {color:#333c4e;}.fusion-widget-area-1 .widget .heading h4 {color:#333c4e;}.fusion-widget-area-1 .widget h4 {font-size:18px;}.fusion-widget-area-1 .widget .heading h4 {font-size:18px;}</style><div class='the_champ_sharing_container the_champ_horizontal_sharing' data-super-socializer-href=\"./wp-json/wp/v2/posts/8435\"><div id=\"thechamphorizontalsharing-2\" class=\"widget widget_thechamphorizontalsharing\"><div class=\"the_champ_sharing_ul\"><a class=\"the_champ_button_linkedin\" href=\"https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2F#%2Fwp-json%2Fwp%2Fv2%2Fposts%2F8435&title=Kinapse%20website%20-%20Kinapse%20website\" title=\"Linkedin\" rel=\"nofollow noopener\" target=\"_blank\" style=\"font-size:24px!important;box-shadow:none;display:inline-block;vertical-align:middle\"><span class=\"the_champ_svg the_champ_s__default the_champ_s_linkedin\" style=\"background-color:#0077b5;width:35px;height:35px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:24px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box\"><svg style=\"display:block;border-radius:999px;\" focusable=\"false\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"100%\" viewBox=\"0 0 32 32\"><path d=\"M6.227 12.61h4.19v13.48h-4.19V12.61zm2.095-6.7a2.43 2.43 0 0 1 0 4.86c-1.344 0-2.428-1.09-2.428-2.43s1.084-2.43 2.428-2.43m4.72 6.7h4.02v1.84h.058c.56-1.058 1.927-2.176 3.965-2.176 4.238 0 5.02 2.792 5.02 6.42v7.395h-4.183v-6.56c0-1.564-.03-3.574-2.178-3.574-2.18 0-2.514 1.7-2.514 3.46v6.668h-4.187V12.61z\" fill=\"#FFF\"></path></svg></span></a><a class=\"the_champ_button_twitter\" href=\"https://twitter.com/intent/tweet?text=The%20Regulatory%20Times%20-%20April%202019&url=https%3A%2F%2F#%2Fwp-json%2Fwp%2Fv2%2Fposts%2F8435\" title=\"Twitter\" rel=\"nofollow noopener\" target=\"_blank\" style=\"font-size:24px!important;box-shadow:none;display:inline-block;vertical-align:middle\"><span class=\"the_champ_svg the_champ_s__default the_champ_s_twitter\" style=\"background-color:#55acee;width:35px;height:35px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:24px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box\"><svg style=\"display:block;border-radius:999px;\" focusable=\"false\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"100%\" viewBox=\"-4 -4 39 39\"><path d=\"M28 8.557a9.913 9.913 0 0 1-2.828.775 4.93 4.93 0 0 0 2.166-2.725 9.738 9.738 0 0 1-3.13 1.194 4.92 4.92 0 0 0-3.593-1.55 4.924 4.924 0 0 0-4.794 6.049c-4.09-.21-7.72-2.17-10.15-5.15a4.942 4.942 0 0 0-.665 2.477c0 1.71.87 3.214 2.19 4.1a4.968 4.968 0 0 1-2.23-.616v.06c0 2.39 1.7 4.38 3.952 4.83-.414.115-.85.174-1.297.174-.318 0-.626-.03-.928-.086a4.935 4.935 0 0 0 4.6 3.42 9.893 9.893 0 0 1-6.114 2.107c-.398 0-.79-.023-1.175-.068a13.953 13.953 0 0 0 7.55 2.213c9.056 0 14.01-7.507 14.01-14.013 0-.213-.005-.426-.015-.637.96-.695 1.795-1.56 2.455-2.55z\" fill=\"#FFF\"></path></svg></span></a><a class=\"the_champ_facebook\" href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2F#%2Fwp-json%2Fwp%2Fv2%2Fposts%2F8435\" title=\"Facebook\" rel=\"nofollow noopener\" target=\"_blank\" style=\"font-size:24px!important;box-shadow:none;display:inline-block;vertical-align:middle\"><span class=\"the_champ_svg\" style=\"background-color:#3c589a;width:35px;height:35px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:24px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box\"><svg style=\"display:block;border-radius:999px;\" focusable=\"false\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"100%\" viewBox=\"-5 -5 42 42\"><path d=\"M17.78 27.5V17.008h3.522l.527-4.09h-4.05v-2.61c0-1.182.33-1.99 2.023-1.99h2.166V4.66c-.375-.05-1.66-.16-3.155-.16-3.123 0-5.26 1.905-5.26 5.405v3.016h-3.53v4.09h3.53V27.5h4.223z\" fill=\"#FFF\"></path></svg></span></a><a class=\"the_champ_more\" title=\"More\" rel=\"nofollow noopener\" style=\"font-size:24px!important;border:0;box-shadow:none;display:inline-block!important;font-size:16px;padding:0 4px;vertical-align: middle;display:inline;\" href=\"./wp-json/wp/v2/posts/8435\" onclick=\"event.preventDefault()\"><span class=\"the_champ_svg\" style=\"background-color:#ee8e2d;width:35px;height:35px;border-radius:999px;display:inline-block!important;opacity:1;float:left;font-size:32px!important;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;display:inline;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box;\" onclick=\"theChampMoreSharingPopup(this, './wp-json/wp/v2/posts/8435', 'Kinapse%20website%20-%20Kinapse%20website', 'The%20Regulatory%20Times%20-%20April%202019' )\"><svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" viewBox=\"-.3 0 32 32\" version=\"1.1\" width=\"100%\" height=\"100%\" style=\"display:block;border-radius:999px;\" xml:space=\"preserve\"><g><path fill=\"#FFF\" d=\"M18 14V8h-4v6H8v4h6v6h4v-6h6v-4h-6z\" fill-rule=\"evenodd\"></path></g></svg></span></a></div></div></div><div class=\"fusion-additional-widget-content\"></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-14 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-top:0px;margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div></div></div></p>\n",
    "protected": false
  },
  "excerpt": {
    "rendered": "<p>Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April&#8217;s edition from Kinapse.</p>\n",
    "protected": false
  },
  "author": 14,
  "featured_media": 8437,
  "comment_status": "open",
  "ping_status": "open",
  "sticky": false,
  "template": "",
  "format": "standard",
  "meta": { "_mi_skip_tracking": false },
  "categories": [35],
  "tags": [],
  "acf": [],
  "yoast_head": "<!-- This site is optimized with the Yoast SEO plugin v19.9 - https://yoast.com/wordpress/plugins/seo/ -->\n<title>Kinapse Blog | The Regulatory Times - April 2019</title>\n<meta name=\"description\" content=\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April&#039;s edition from Kinapse.\" />\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" />\n<link rel=\"canonical\" href=\"./blog/regulatory-times-april-2019/\" />\n<meta property=\"og:locale\" content=\"en_GB\" />\n<meta property=\"og:type\" content=\"article\" />\n<meta property=\"og:title\" content=\"The Regulatory Times - April 2019\" />\n<meta property=\"og:description\" content=\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April&#039;s edition from Kinapse.\" />\n<meta property=\"og:url\" content=\"./blog/regulatory-times-april-2019/\" />\n<meta property=\"og:site_name\" content=\"Kinapse website\" />\n<meta property=\"article:published_time\" content=\"2019-05-28T15:42:19+00:00\" />\n<meta property=\"article:modified_time\" content=\"2019-05-28T16:21:43+00:00\" />\n<meta property=\"og:image\" content=\"./wp-content/uploads/2019/05/Asset-9.jpg\" />\n\t<meta property=\"og:image:width\" content=\"1200\" />\n\t<meta property=\"og:image:height\" content=\"800\" />\n\t<meta property=\"og:image:type\" content=\"image/jpeg\" />\n<meta name=\"author\" content=\"Ed Ricketts\" />\n<meta name=\"twitter:card\" content=\"summary_large_image\" />\n<meta name=\"twitter:title\" content=\"The Regulatory Times - April 2019\" />\n<meta name=\"twitter:description\" content=\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April&#039;s edition from Kinapse.\" />\n<meta name=\"twitter:image\" content=\"./wp-content/uploads/2019/05/Asset-9.jpg\" />\n<meta name=\"twitter:label1\" content=\"Written by\" />\n\t<meta name=\"twitter:data1\" content=\"Ed Ricketts\" />\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" />\n\t<meta name=\"twitter:data2\" content=\"16 minutes\" />\n<script type=\"application/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https://schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"./blog/regulatory-times-april-2019/\",\"url\":\"./blog/regulatory-times-april-2019/\",\"name\":\"Kinapse Blog | The Regulatory Times - April 2019\",\"isPartOf\":{\"@id\":\"./#website\"},\"datePublished\":\"2019-05-28T15:42:19+00:00\",\"dateModified\":\"2019-05-28T16:21:43+00:00\",\"author\":{\"@id\":\"./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6\"},\"description\":\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April's edition from Kinapse.\",\"breadcrumb\":{\"@id\":\"./blog/regulatory-times-april-2019/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"./blog/regulatory-times-april-2019/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"./blog/regulatory-times-april-2019/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"./\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Regulatory Times &#8211; April 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"./#website\",\"url\":\"./\",\"name\":\"Kinapse website\",\"description\":\"Kinapse website\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"./?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6\",\"name\":\"Ed Ricketts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"./#/schema/person/image/\",\"url\":\"https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g\",\"contentUrl\":\"https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g\",\"caption\":\"Ed Ricketts\"},\"sameAs\":[\"http://#\"],\"url\":\"./author/ed-ricketts/\"}]}</script>\n<!-- / Yoast SEO plugin. -->",
  "yoast_head_json": {
    "title": "Kinapse Blog | The Regulatory Times - April 2019",
    "description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April's edition from Kinapse.",
    "robots": {
      "index": "index",
      "follow": "follow",
      "max-snippet": "max-snippet:-1",
      "max-image-preview": "max-image-preview:large",
      "max-video-preview": "max-video-preview:-1"
    },
    "canonical": "./blog/regulatory-times-april-2019/",
    "og_locale": "en_GB",
    "og_type": "article",
    "og_title": "The Regulatory Times - April 2019",
    "og_description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April's edition from Kinapse.",
    "og_url": "./blog/regulatory-times-april-2019/",
    "og_site_name": "Kinapse website",
    "article_published_time": "2019-05-28T15:42:19+00:00",
    "article_modified_time": "2019-05-28T16:21:43+00:00",
    "og_image": [
      {
        "width": 1200,
        "height": 800,
        "url": "./wp-content/uploads/2019/05/Asset-9.jpg",
        "type": "image/jpeg"
      }
    ],
    "author": "Ed Ricketts",
    "twitter_card": "summary_large_image",
    "twitter_title": "The Regulatory Times - April 2019",
    "twitter_description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April's edition from Kinapse.",
    "twitter_image": "./wp-content/uploads/2019/05/Asset-9.jpg",
    "twitter_misc": {
      "Written by": "Ed Ricketts",
      "Estimated reading time": "16 minutes"
    },
    "schema": {
      "@context": "https://schema.org",
      "@graph": [
        {
          "@type": "WebPage",
          "@id": "./blog/regulatory-times-april-2019/",
          "url": "./blog/regulatory-times-april-2019/",
          "name": "Kinapse Blog | The Regulatory Times - April 2019",
          "isPartOf": { "@id": "./#website" },
          "datePublished": "2019-05-28T15:42:19+00:00",
          "dateModified": "2019-05-28T16:21:43+00:00",
          "author": {
            "@id": "./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6"
          },
          "description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April's edition from Kinapse.",
          "breadcrumb": {
            "@id": "./blog/regulatory-times-april-2019/#breadcrumb"
          },
          "inLanguage": "en-GB",
          "potentialAction": [
            {
              "@type": "ReadAction",
              "target": ["./blog/regulatory-times-april-2019/"]
            }
          ]
        },
        {
          "@type": "BreadcrumbList",
          "@id": "./blog/regulatory-times-april-2019/#breadcrumb",
          "itemListElement": [
            {
              "@type": "ListItem",
              "position": 1,
              "name": "Home",
              "item": "./"
            },
            {
              "@type": "ListItem",
              "position": 2,
              "name": "The Regulatory Times &#8211; April 2019"
            }
          ]
        },
        {
          "@type": "WebSite",
          "@id": "./#website",
          "url": "./",
          "name": "Kinapse website",
          "description": "Kinapse website",
          "potentialAction": [
            {
              "@type": "SearchAction",
              "target": {
                "@type": "EntryPoint",
                "urlTemplate": "./?s={search_term_string}"
              },
              "query-input": "required name=search_term_string"
            }
          ],
          "inLanguage": "en-GB"
        },
        {
          "@type": "Person",
          "@id": "./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6",
          "name": "Ed Ricketts",
          "image": {
            "@type": "ImageObject",
            "inLanguage": "en-GB",
            "@id": "./#/schema/person/image/",
            "url": "https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g",
            "contentUrl": "https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g",
            "caption": "Ed Ricketts"
          },
          "sameAs": ["http://#"],
          "url": "./author/ed-ricketts/"
        }
      ]
    }
  },
  "_links": {
    "self": [{ "href": "./wp-json/wp/v2/posts/8435" }],
    "collection": [{ "href": "./wp-json/wp/v2/posts" }],
    "about": [{ "href": "./wp-json/wp/v2/types/post" }],
    "author": [
      { "embeddable": true, "href": "./wp-json/wp/v2/users/14" }
    ],
    "replies": [
      {
        "embeddable": true,
        "href": "./wp-json/wp/v2/comments?post=8435"
      }
    ],
    "version-history": [
      { "count": 3, "href": "./wp-json/wp/v2/posts/8435/revisions" }
    ],
    "predecessor-version": [
      {
        "id": 9469,
        "href": "./wp-json/wp/v2/posts/8435/revisions/9469"
      }
    ],
    "wp:featuredmedia": [
      { "embeddable": true, "href": "./wp-json/wp/v2/media/8437" }
    ],
    "wp:attachment": [{ "href": "./wp-json/wp/v2/media?parent=8435" }],
    "wp:term": [
      {
        "taxonomy": "category",
        "embeddable": true,
        "href": "./wp-json/wp/v2/categories?post=8435"
      },
      {
        "taxonomy": "post_tag",
        "embeddable": true,
        "href": "./wp-json/wp/v2/tags?post=8435"
      }
    ],
    "curies": [
      { "name": "wp", "href": "https://api.w.org/{rel}", "templated": true }
    ]
  }
}
